NeuroGlympse

NeuroGlympse is a private digital health and tele-neurology company focused on diagnosis, monitoring, and care coordination for mild traumatic brain injury and related neuropsychiatric symptoms. The company markets a remote therapeutic monitoring platform that uses facial photoplethysmography, deep neural networks, ocular biomarkers, and connected assessments to generate objective neurological data for clinicians, patients, and legal stakeholders. Its services emphasize concussion and mTBI evaluation, neurologist-centered review, longitudinal symptom tracking, and access to FDA-cleared diagnostic or therapeutic devices. NeuroGlympse appears to operate as a commercial healthcare services and software-enabled care company rather than a drug developer, with offerings spanning patient monitoring, clinical workflow tools, and neurotechnology-enabled care pathways.